Home / Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Inc. (RARE) Technical Analysis

Updated: 2026-03-17 00:40 UTC · Last close: 21.82 (+2.25%)
Ultragenyx Pharmaceutical Inc. (RARE) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Support
20.35
Resistance
24.00
Ultragenyx Pharmaceutical Inc. (RARE) finished the session at 21.82 (+2.25%). With price below both the 50-day and 200-day moving averages, the broader structure still reflects elevated technical pressure. 20-day momentum is positive at +6.34%, with price is trading in the lower part of its roughly 52-week range (19.72–41.44), while ATR14 volatility is running near 4.15% of price. RSI(14) is 44.2, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The most important nearby levels are support at 20.35 and resistance at 24.00. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: -575.00M · EPS (basic): -5.83. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
Fundamentals Snapshot
Source: sec
Company
Ultragenyx Pharmaceutical Inc.
CIK (SEC ID)
0001515673
Shares Out.
96.60M
Net Income
-575.00M
EPS (Basic)
-5.83
Explore more
Alphabet (GOOG) technical analysisMeta Platforms (META) technical analysisTesla (TSLA) technical analysisBroadcom (AVGO) technical analysisJPMorgan Chase & Co (JPM) technical analysisVisa (V) technical analysisMastercardorporated (MA) technical analysis
WOI OPEN FULL INTERACTIVE ANALYSIS
Note: This is an algorithmic technical snapshot (not financial advice).
RARE Chart